Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hyperlipoproteinemias

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    June 2021
  1. RUBIN R
    Could Statins Do More Than Lower Cholesterol in Patients With COVID-19?
    JAMA. 2021 Jun 3. pii: 2780872. doi: 10.1001/jama.2021.8201.
    PubMed    


    November 2020
  2. NICHOLLS SJ, Lincoff AM, Garcia M, Bash D, et al
    Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    JAMA. 2020 Nov 15. pii: 2773120. doi: 10.1001/jama.2020.22258.
    PubMed     Abstract available


    June 2020
  3. KURTH T, Rist PM, Ridker PM, Kotler G, et al
    Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.
    JAMA. 2020;323:2281-2289.
    PubMed     Abstract available


    March 2020
  4. ABBASI J
    Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    JAMA. 2020 Mar 18. pii: 2763421. doi: 10.1001/jama.2019.20983.
    PubMed    


    December 2019
  5. SLOMSKI A
    Statins in Childhood May Reduce CVD From Familial Hypercholesterolemia.
    JAMA. 2019;322:2375.
    PubMed    


    November 2019
  6. HONIGBERG MC, Zekavat SM, Aragam K, Finneran P, et al
    Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.
    JAMA. 2019 Nov 18. pii: 2755841. doi: 10.1001/jama.2019.19191.
    PubMed     Abstract available


  7. GOLDBERG AC, Leiter LA, Stroes ESG, Baum SJ, et al
    Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
    JAMA. 2019;322:1780-1788.
    PubMed     Abstract available


    August 2019
  8. SKOLNIK N
    Treating Hypercholesterolemia in Older Adults-Reply.
    JAMA. 2019;322:695-696.
    PubMed    


  9. FORMAN DE, Stone NJ, Grundy SM
    Treating Hypercholesterolemia in Older Adults.
    JAMA. 2019;322:695.
    PubMed    


    May 2019
  10. PERAK AM, Ning H, Kit BK, de Ferranti SD, et al
    Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.
    JAMA. 2019;321:1895-1905.
    PubMed     Abstract available


    March 2019
  11. SKOLNIK N
    Reexamining Recommendations for Treatment of Hypercholesterolemia in Older Adults.
    JAMA. 2019 Mar 11. pii: 2728377. doi: 10.1001/jama.2019.1676.
    PubMed    


    February 2019
  12. ALENGHAT FJ, Davis AM
    Management of Blood Cholesterol.
    JAMA. 2019;321:800-801.
    PubMed    


  13. ABBASI J
    New Cholesterol Guidelines Personalize Risk and Add Treatments.
    JAMA. 2019;321:731-732.
    PubMed    


    January 2019
  14. NAGPAL SJS, Chari ST
    Immunoglobulin G4 Levels.
    JAMA. 2019;321:202-203.
    PubMed    


    October 2018
  15. KING WC, Hinerman AS, Belle SH, Wahed AS, et al
    Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.
    JAMA. 2018;320:1560-1569.
    PubMed     Abstract available


    January 2018
  16. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Abstract available


    December 2017
  17. GREENLAND P
    Cardiovascular Guideline Skepticism vs Lifestyle Realism?
    JAMA. 2017 Dec 14. pii: 2666625. doi: 10.1001/jama.2017.19675.
    PubMed    


    August 2017
  18. FERENCE BA, Kastelein JJP, Ginsberg HN, Chapman MJ, et al
    Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    JAMA. 2017 Aug 28. doi: 10.1001/jama.2017.11467.
    PubMed     Abstract available


  19. KAZI DS, Penko J, Coxson PG, Moran AE, et al
    Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.
    JAMA. 2017;318:748-750.
    PubMed    


  20. KRUMHOLZ HM
    Treatment of Cholesterol in 2017.
    JAMA. 2017;318:417-418.
    PubMed    


    July 2017
  21. KNOWLES JW, Rader DJ, Khoury MJ
    Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    JAMA. 2017;318:381-382.
    PubMed    


  22. IOANNIDIS JPA
    Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.
    JAMA. 2017 Jul 24. doi: 10.1001/jama.2017.6765.
    PubMed    


    April 2017
  23. SCHWARTZ MLB, Williams MS, Murray MF
    Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance.
    JAMA. 2017;317:1527-1528.
    PubMed    


  24. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: